Product Images Sildenafil

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Sildenafil NDC 68071-2985 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

pdp - 68071 2985 3

pdp - 68071 2985 3

NuCare Pharmaceuticals Inc. produces a medication named Sildenafil 100mg. This medication has Lot number 00000 and NDC 68071-2985-03. Two units of this medication have serial numbers 0000000002. It is recommended to store this medication at a controlled temperature of 68-77°F. In case of any side effects, patients may report them to FDA at 1-800-FDA-1088.*

10 - sildenafil tablets 25 50 100 1

10 - sildenafil tablets 25 50 100 1

10 - sildenafil tablets 25 50 100 2

10 - sildenafil tablets 25 50 100 2

10 - sildenafil tablets 25 50 100 3

10 - sildenafil tablets 25 50 100 3

This is a graph showing the change in systolic blood pressure (SBP) in mmHg over time (in hours) after the administration of Doxazosin alone and in combination with Sildenafil 25mg. The graph shows a decrease in SBP for both treatments, with a more significant decrease observed when Doxazosin was combined with Sildenafil 25mg.*

10 - sildenafil tablets 25 50 100 4

10 - sildenafil tablets 25 50 100 4

This appears to be a graph displaying the change in systolic blood pressure (SBP) in millimeters of mercury (mmHg) over time in hours. The graph shows the comparison between two treatments: Doxazosin + Placebo and Doxazosin + Sildenafil 50 mg. The values on the y-axis range from -50 to 0, indicating a decrease in SBP. The x-axis displays time post-dose in hours, ranging from 0 to 8 hours.*

10 - sildenafil tablets 25 50 100 5

10 - sildenafil tablets 25 50 100 5

This is a chart showing blood pressure measurements in millimeters of mercury (mmHg) over time after administering different treatments (Doxazosin and Sildenafil, Doxazosin and Placebo). There is no other information available.*

10 - sildenafil tablets 25 50 100 6

10 - sildenafil tablets 25 50 100 6

This data appears to be a table showing plasma concentrations (in ng/ml) at different time points post dose (in hrs) for a commercial tablet treatment. However, without more context or information, it is difficult to provide a more detailed or specific description of the data.*

10 - sildenafil tablets 25 50 100 7

10 - sildenafil tablets 25 50 100 7

10 - sildenafil tablets 25 50 100 8

10 - sildenafil tablets 25 50 100 8

10 - sildenafil tablets 25 50 100 9

10 - sildenafil tablets 25 50 100 9

This seems to be a table or chart containing percentages and values related to different dosages of Placebo and Sildenafil. The treatments were allocated in different groups, and there is a test result indicating a significant difference among the groups. However, without more context or understanding of the subject matter, it's not possible to provide a more detailed description.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.